2 completed, 1 withdrawn. 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Chronocort®: new trials by email Literature Review of Chronocort® trials Research Report on Chronocort®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy Chronocort®, Standard Care - Congenital Adrenal Hyperplasia | Phase 3 | Withdrawn | Neurocrine UK Limited | 2018-10-04 | 2026-09-14 | |
| A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects Chronocort®, Cortef® - Adrenal Insufficiency | Phase 1 | Completed | Neurocrine UK Limited | 25 | 2018-02-19 | 2026-09-14 |
| Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia Chronocort®, standard glucocorticoid therapy - Congenital Adrenal Hyperplasia | Phase 3 | Completed | Neurocrine UK Limited | 122 | 2016-02-22 | 2026-10-02 |
Adrenal Hyperplasia, Congenital (2) · Adrenal Insufficiency (1)
United States (2) · United Kingdom (1)
A Koch (1) · Debbie Merke, MD (1)